EP3768305 - MODIFIED ONCOLYTIC ADENOVIRUSES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.10.2023 Database last updated on 08.10.2024 | |
Former | The patent has been granted Status updated on 28.10.2022 | ||
Former | Grant of patent is intended Status updated on 30.08.2022 | ||
Former | Examination is in progress Status updated on 17.12.2021 | ||
Former | Request for examination was made Status updated on 25.12.2020 | ||
Former | The international publication has been made Status updated on 28.09.2019 | ||
Former | unknown Status updated on 02.04.2019 | Most recent event Tooltip | 16.02.2024 | Lapse of the patent in a contracting state New state(s): BE | published on 20.03.2024 [2024/12] | Applicant(s) | For all designated states Valo Therapeutics Oy Cultivator 1 Viikinkaari 6 00790 Helsinki / FI | [2021/04] | Inventor(s) | 01 /
RANKI, Tuuli Valo Therapeutics Oy Cultivator 1 Viikinkaari 6 00790 Helsinki / FI | 02 /
PESONEN, Sari Valo Therapeutics Oy Cultivator 1 Viikinkaari 6 00790 Helsinki / FI | 03 /
PRIHA, Petri Valo Therapeutics Oy Cultivator 1 Viikinkaari 6 00790 Helsinki / FI | 04 /
YLÖSMÄKI, Erkko Valo Therapeutics Oy Cultivator 1 Viikinkaari 6 00790 Helsinki / FI | 05 /
CERULLO, Vincenzo Valo Therapeutics Oy Cultivator 1 Viikinkaari 6 00790 Helsinki / FI | 06 /
MARTINS, Beatriz Valo Therapeutics Oy Cultivator 1 Viikinkaari 6 00790 Helsinki / FI | [2021/04] | Representative(s) | Myint, Julie Marie Symbiosis IP Limited Cardiff MediCentre Heath Park Cardiff CF14 4UJ / GB | [2021/04] | Application number, filing date | 19712178.3 | 19.03.2019 | [2021/04] | WO2019EP56768 | Priority number, date | GB20180004473 | 21.03.2018 Original published format: GB 201804473 | GB20180014867 | 13.09.2018 Original published format: GB 201814867 | [2021/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019179977 | Date: | 26.09.2019 | Language: | EN | [2019/39] | Type: | A1 Application with search report | No.: | EP3768305 | Date: | 27.01.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.09.2019 takes the place of the publication of the European patent application. | [2021/04] | Type: | B1 Patent specification | No.: | EP3768305 | Date: | 30.11.2022 | Language: | EN | [2022/48] | Search report(s) | International search report - published on: | EP | 26.09.2019 | Classification | IPC: | A61K39/00, A61K35/761, C12N7/00, C12N15/86 | [2021/04] | CPC: |
C12N15/86 (EP);
C12N7/00 (KR,US);
A61K35/761 (EP,KR,US);
A61K39/0011 (EP,KR,US);
A61K39/001186 (EP,KR,US);
A61K39/001188 (EP,KR,US);
A61K45/06 (US);
A61P35/00 (EP,KR,US);
A61K2039/525 (KR);
A61K2039/54 (KR);
A61K2039/545 (KR);
A61K2039/6031 (EP,KR);
A61K2039/80 (KR);
A61K2039/876 (EP);
C07K14/70575 (EP);
C12N2710/10321 (US);
C12N2710/10322 (KR);
C12N2710/10332 (EP,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/04] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | MODIFIZIERTE ONKOLYTISCHE ADENOVIREN | [2021/04] | English: | MODIFIED ONCOLYTIC ADENOVIRUSES | [2021/04] | French: | ADÉNOVIRUS ONCOLYTIQUES MODIFIÉS | [2021/04] | Entry into regional phase | 23.09.2020 | National basic fee paid | 23.09.2020 | Designation fee(s) paid | 23.09.2020 | Examination fee paid | Examination procedure | 16.08.2019 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 23.09.2020 | Examination requested [2021/04] | 23.09.2020 | Date on which the examining division has become responsible | 19.03.2021 | Amendment by applicant (claims and/or description) | 16.12.2021 | Despatch of a communication from the examining division (Time limit: M02) | 21.12.2021 | Reply to a communication from the examining division | 31.08.2022 | Communication of intention to grant the patent | 20.10.2022 | Fee for grant paid | 20.10.2022 | Fee for publishing/printing paid | 20.10.2022 | Receipt of the translation of the claim(s) | Opposition(s) | 31.08.2023 | No opposition filed within time limit [2023/45] | Fees paid | Renewal fee | 15.03.2021 | Renewal fee patent year 03 | 10.03.2022 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 30.11.2022 | AT | 30.11.2022 | EE | 30.11.2022 | HR | 30.11.2022 | LT | 30.11.2022 | LV | 30.11.2022 | MC | 30.11.2022 | PL | 30.11.2022 | RO | 30.11.2022 | RS | 30.11.2022 | SI | 30.11.2022 | SK | 30.11.2022 | SM | 30.11.2022 | GR | 01.03.2023 | IE | 19.03.2023 | LU | 19.03.2023 | IS | 30.03.2023 | BE | 31.03.2023 | PT | 31.03.2023 | [2024/12] |
Former [2024/08] | AL | 30.11.2022 | |
AT | 30.11.2022 | ||
EE | 30.11.2022 | ||
HR | 30.11.2022 | ||
LT | 30.11.2022 | ||
LV | 30.11.2022 | ||
MC | 30.11.2022 | ||
PL | 30.11.2022 | ||
RO | 30.11.2022 | ||
RS | 30.11.2022 | ||
SI | 30.11.2022 | ||
SK | 30.11.2022 | ||
SM | 30.11.2022 | ||
GR | 01.03.2023 | ||
IE | 19.03.2023 | ||
LU | 19.03.2023 | ||
IS | 30.03.2023 | ||
PT | 31.03.2023 | ||
Former [2024/02] | AL | 30.11.2022 | |
AT | 30.11.2022 | ||
EE | 30.11.2022 | ||
HR | 30.11.2022 | ||
LT | 30.11.2022 | ||
LV | 30.11.2022 | ||
MC | 30.11.2022 | ||
PL | 30.11.2022 | ||
RO | 30.11.2022 | ||
RS | 30.11.2022 | ||
SI | 30.11.2022 | ||
SK | 30.11.2022 | ||
SM | 30.11.2022 | ||
GR | 01.03.2023 | ||
LU | 19.03.2023 | ||
IS | 30.03.2023 | ||
PT | 31.03.2023 | ||
Former [2023/51] | AL | 30.11.2022 | |
AT | 30.11.2022 | ||
EE | 30.11.2022 | ||
HR | 30.11.2022 | ||
LT | 30.11.2022 | ||
LV | 30.11.2022 | ||
MC | 30.11.2022 | ||
PL | 30.11.2022 | ||
RO | 30.11.2022 | ||
RS | 30.11.2022 | ||
SI | 30.11.2022 | ||
SK | 30.11.2022 | ||
SM | 30.11.2022 | ||
GR | 01.03.2023 | ||
IS | 30.03.2023 | ||
PT | 31.03.2023 | ||
Former [2023/48] | AL | 30.11.2022 | |
AT | 30.11.2022 | ||
EE | 30.11.2022 | ||
HR | 30.11.2022 | ||
LT | 30.11.2022 | ||
LV | 30.11.2022 | ||
MC | 30.11.2022 | ||
PL | 30.11.2022 | ||
RO | 30.11.2022 | ||
RS | 30.11.2022 | ||
SK | 30.11.2022 | ||
SM | 30.11.2022 | ||
GR | 01.03.2023 | ||
IS | 30.03.2023 | ||
PT | 31.03.2023 | ||
Former [2023/38] | AL | 30.11.2022 | |
AT | 30.11.2022 | ||
EE | 30.11.2022 | ||
HR | 30.11.2022 | ||
LT | 30.11.2022 | ||
LV | 30.11.2022 | ||
PL | 30.11.2022 | ||
RO | 30.11.2022 | ||
RS | 30.11.2022 | ||
SK | 30.11.2022 | ||
SM | 30.11.2022 | ||
GR | 01.03.2023 | ||
IS | 30.03.2023 | ||
PT | 31.03.2023 | ||
Former [2023/37] | AL | 30.11.2022 | |
AT | 30.11.2022 | ||
EE | 30.11.2022 | ||
HR | 30.11.2022 | ||
LT | 30.11.2022 | ||
LV | 30.11.2022 | ||
PL | 30.11.2022 | ||
RO | 30.11.2022 | ||
RS | 30.11.2022 | ||
SM | 30.11.2022 | ||
GR | 01.03.2023 | ||
IS | 30.03.2023 | ||
PT | 31.03.2023 | ||
Former [2023/35] | AT | 30.11.2022 | |
EE | 30.11.2022 | ||
HR | 30.11.2022 | ||
LT | 30.11.2022 | ||
LV | 30.11.2022 | ||
PL | 30.11.2022 | ||
RO | 30.11.2022 | ||
RS | 30.11.2022 | ||
SM | 30.11.2022 | ||
GR | 01.03.2023 | ||
IS | 30.03.2023 | ||
PT | 31.03.2023 | ||
Former [2023/34] | EE | 30.11.2022 | |
HR | 30.11.2022 | ||
LT | 30.11.2022 | ||
LV | 30.11.2022 | ||
PL | 30.11.2022 | ||
RS | 30.11.2022 | ||
SM | 30.11.2022 | ||
GR | 01.03.2023 | ||
IS | 30.03.2023 | ||
PT | 31.03.2023 | ||
Former [2023/33] | HR | 30.11.2022 | |
LT | 30.11.2022 | ||
LV | 30.11.2022 | ||
PL | 30.11.2022 | ||
RS | 30.11.2022 | ||
SM | 30.11.2022 | ||
GR | 01.03.2023 | ||
IS | 30.03.2023 | ||
PT | 31.03.2023 | ||
Former [2023/25] | HR | 30.11.2022 | |
LT | 30.11.2022 | ||
LV | 30.11.2022 | ||
PL | 30.11.2022 | ||
RS | 30.11.2022 | ||
GR | 01.03.2023 | ||
IS | 30.03.2023 | ||
PT | 31.03.2023 | ||
Former [2023/23] | LT | 30.11.2022 | |
LV | 30.11.2022 | ||
GR | 01.03.2023 | ||
PT | 31.03.2023 | ||
Former [2023/22] | LT | 30.11.2022 | |
PT | 31.03.2023 | ||
Former [2023/20] | LT | 30.11.2022 | Cited in | International search | [Y]WO2014170389 (TILT BIOTHERAPEUTICS OY [FI]); | [Y]WO2017205875 (DNATRIX INC [US], et al); | [Y]WO2018046803 (TARGOVAX OY [FI]); |